High vancomycin resistance among biofilms produced by Staphylococcus species isolated from central venous catheters

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 1, 2011, Pages 51-55

  Antunes, Ana Lúcia Souza ^a   Bonfanti, Jéssica Weis ^a   Perez, Leandro Reus Rodrigues ^a   Pinto, Camille Cattani Ferreira ^a   de Freitas, Ana Lúcia Peixoto ^a   Macedo, Alexandre José ^a   Barth, Afonso Luis ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Biofilm; Staphylococcus spp; Vancomycin

Indexed keywords

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

EID: 79851476466     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762011000100008     Document Type: Article

References (22)

1. Amorena B, Gracia E, Monzón M, Leiva J, Oteiza C, Pérez M, Alabart JL, Hernández-Yago J 1999. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44: 43-55.
2. Antunes AL, Secchi C, Reiter KC, Perez LR, de Freitas AL, D'Azevedo PA 2008. Feasible identification of Staphylococcus epidermidis using desferrioxamine and fosfomycin disks. APMIS 116: 16-20.
3. CLSI - Clinical and Laboratory Standards Institute 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved Standard, NCCLS document M7-A6, 6th ed., CLSI/NCCLS, Wayne, 1-25.
4. CLSI - Clinical and Laboratory Standards Institute 2009. Performance standards for antimicrobial disk susceptibility testing, 19th informational supplement, CLSI, Wayne, 10 pp.
5. Frank KL, Reichert EJ, Piper KE, Patel R 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms on Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother 51: 888-895.
6. Glansdorp FG, Spandl RJ, Swatton JE, Loiseleur O, Welch M, Spring DR 2008. Using chemical probes to investigate the sub-inhibitory effects of azythromycin. Org Biomol Chem 6: 4120-4124.
7. Graninger W, Assadian O, Lagler H, Ramharter M 2002. The role of glycopeptides in the treatment of intravascular catheter-related infections. Clin Microbiol Infect 8: 310-315.
8. Hajdu S, Lassnigg A, Graninger W, Hirschl AM, Presterl E 2009. Effects of vancomycin, daptomycin, fosfomycin, tigecycline and ceftriaxone on Staphylococcus epidermidis biofilms. J Orthop Res 27: 1361-1365.
9. Jefferson KK, Goldmann DA, Pier GB 2005. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 49: 2467-2473.
10. LaPlante KL, Mermel LA 2007. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model. Nephrol Dial Transplant 22: 2239-2246.
11. Maki DG, Jarrett F, Sarafin HW 1977. A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res 22: 513-520.
12. Monaco M, Sanchini A, Grundmann H, Pantosti A 2010. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J Clin Microbiol Infect Dis 29: 771-777.
13. Moskowitz SM, Foster JM, Emerson J, Burns JL 2004. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42: 1915-1922.
14. Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R 2009. Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years. J Clin Microbiol 47: 1640-1644.
15. Presterl E, Hajdu S, Lassnigg AM, Hirschl AM, Holinka J, Graninger W 2009. Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline and ceftriaxone on Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 53: 3205-3210.
16. Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R 2007. Comparative activities of daptomycin, linezolid and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51: 1656-60.
17. Rice LB 2006. Antimicrobial resistance in gram-positive bacteria. Am J Med 119 (Suppl. 1): S11-S19.
18. Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, Dalovisio JR, Levine DP 2009. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm 66: 82-98.
19. Sakoulas G, Eliopoulos GM, Fowler VG Jr, Moellering RC Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS 2005. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother 49: 2687-2692.
20. Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, Ruzicka F 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115: 891-899.
21. Stewart PS 2002. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292: 107-113.
22. Tenover FC 2006. Mechanisms of antimicrobial resistance in bacteria. Am J Med 119 (Suppl. 1): S3-S10.